comparemela.com

Latest Breaking News On - Paul peloso - Page 1 : comparemela.com

CRISPR Tx finds CMO in Sanofi leader—Chutes & Ladders

CRISPR Tx finds CMO in Sanofi leader—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

France
French
Julianne-bruno
Naimish-patel
Nicole-gormley
Kronos-bio
Novartis-linkedin
John-puisis
Deborah-knobelman
Jeffrey-young
Harpreet-singh
John-bishop

Acelyrin (SLRN) Q2 2023 Earnings Call Transcript

SLRN earnings call for the period ending June 30, 2023.

United-states
Vikram-purohit-morgan-stanley
Akash-tewari-jefferies
Shao-lee-lin
Gil-labrucherie
Akash-tewari
Vikram-purohit
Piper-sandler
Paul-peloso
John-gou
Tyler-van-buren
Tyler-marciniak

Acelyrin follows Kenvue with largest IPO for a biotech startup since 2021

BioPharma

California
United-states
Sweden
Agoura-hills
Swedish
Shao-lee-lin
Mike-perrone
Novartis-cosentyx
Eli-lilly-taltz
Bill-smith
Paul-peloso
Nasdaq

Acelyrin sets hopes high for arthritis drug with $300M fundraise

BioPharma

Sweden
California
United-states
Californian
Swedish
Novartis-cosentyx
Eli-lilly-taltz
Shao-lee-lin
Paul-peloso
Amgen
Bausch-health-siliq
Los-angeles-based

Affibody, ACELYRIN, and Inmagene Bio Announce Positive Results from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis

Affibody, ACELYRIN, and Inmagene Bio Announce Positive Results from Global Phase 2 Trial of Izokibep in Patients with Psoriatic ArthritisSolna, Sweden, Los.

China
Sweden
Solna
Stockholm
United-states
Shanghai
Los-angeles
Nikolai-brun
Shao-lee-lin
David-bejker
Paul-peloso
Inmagene-biopharmaceuticals-co-ltd

vimarsana © 2020. All Rights Reserved.